Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Head of OCDEM
© Martin Phelps
Diabetes Trials Unit
The Diabetes Trials Unit (DTU) is a fully registered UKCRC Clinical Trials Unit, specialising in performing national and multinational clinical trials related to diabetes.
Read moreAbout OCDEM
The Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases.
Read moreGene that contributes to female body shape may increase risk of type 2 diabetes
Scientists at the University of Oxford have identified a gene that in women is linked to the creation and location of new fat cells and in turn contributes to an increased risk of type 2 diabetes.
Read moreThere was an error while rendering this tile
Our Wednesday seminars are supported by an unrestricted educational grant from Boehringer-Ingelheim
Latest Publications
-
δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin.
Briant LJB. et al, (2018), J Physiol, 596, 197 - 215
-
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Mentz RJ. et al, (2017), Am Heart J, 187, 1 - 9
-
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Holman RR. et al, (2017), Lancet Diabetes Endocrinol, 5, 877 - 886
-
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
Howles SA. et al, (2017), JCI Insight, 2
OCDEM Vacancies